Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.

Completion of SON-1010 (IL12-FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

I see this bill as being less problematic with appeals in the courts,” said Rep. Bruce Skaug, R-Nampa, who proposed the change in law.

Cases of Guillain-Barre Syndrome (GBS) are on the rise, triggering concern among health officials. As of January 29, a total ...

PyroGenesis Inc. (“PyroGenesis”) ( (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company that designs, develops, ...

Mozambique will begin producing vaccines and large volume parenterals (LVPs) this year, ensuring their timely availability in the National Health Service (NHS) for the prevention of diseases, ...

RYBREVANT and LAZCLUZE showed significant in overall survival in first line treatment of advanced ... and FDA clearance of Shockwave's Javelin Peripheral IVL Catheter for the treatment of tight ...